At SOZO Brain Center, innovation in neuromodulation treatments continues to be at the center of our mission to provide cutting-edge solutions for neurological, mental and chronic conditions. We are thrilled to announce that we now offer Transcranial Pulse Stimulation (TPS), a groundbreaking technology for treating Alzheimer’s disease. Our team of doctors has recently undergone specialized training to implement this advanced therapy, further enhancing our commitment to delivering unprecedented patient care.
What is TPS?
Transcranial Pulse Stimulation (TPS) is an innovative neuromodulation therapy that uses low-energy shock waves to introduce energy into cerebral tissue. Unlike traditional shock wave treatments that use high-energy waves, TPS is specifically designed for neurological applications, offering a non-invasive, targeted approach to stimulate deep brain regions.
Originally developed and studied at the University of Vienna, TPS has been CE-marked since 2018 for the treatment of Alzheimer’s disease. It represents a significant asset in neurological care, providing a safe and effective outpatient treatment option with minimal discomfort for patients.
Advantages of TPS
TPS is an ideal choice for treating Alzheimer’s disease and other neurological conditions as it offers:
- Targeted Deep Stimulation: TPS enables precise stimulation of cerebral regions, addressing the specific areas affected by Alzheimer’s.
- Non-Invasive and Convenient: Treatment sessions are straightforward and do not require any surgical procedures or even head shaving.
- Short Sessions: Each session lasts approximately 30 minutes, with a typical treatment plan consisting of six sessions over two weeks.
- Real-Time Visualisation: The applied pulses are visualized in real-time, offering accurate monitoring during the procedure.
BodyTrack®: Real-Time 3D Treatment Documentation
A key feature of TPS therapy is the integration of the BodyTrack® software, a revolutionary tool that enhances precision and personalization in treatment. This system leverages patients’ MRI data to:
- Display individual brain features in three perspectives.
- Automatically adjust target regions based on handpiece position.
- Provide color-coded visualisation of the treatment zone and energy distribution.
- Document the course of treatment in real-time, ensuring optimal outcomes.
Clinical Impact of TPS
Since its first use in 2015 during studies at the University of Vienna, TPS has shown promising results in improving cognitive function and quality of life for Alzheimer’s patients. While Alzheimer’s remains the primary focus, ongoing clinical research is exploring its potential applications for other neurological conditions, such as Parkinson’s disease.
Why Choose SOZO Brain Center for TPS?
At SOZO Brain Center, we pride ourselves on being leaders in advanced neuromodulation treatments. With our newly acquired TPS technology and our team’s specialized training, we are now fully equipped to provide this therapy to our patients. By combining cutting-edge tools like the NEUROLITH® system and BodyTrack® software with our commitment to patient-centered care, we strive to deliver unparalleled treatment experiences and outcomes.
Looking Ahead
As we continue to expand our expertise and offerings, TPS marks another milestone in our mission to revolutionize neurological care. For individuals and families affected by Alzheimer’s, this technology offers renewed hope and tangible improvements in daily living.
To learn more about TPS and how it can benefit you or your loved ones, contact SOZO Brain Center today to schedule a consultation. Together, we can create a brighter future in neurological health.
